[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368454-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368454-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","isomas-finding-isoform-expression-and-somatic-mutation-associations-in-human-cancers","iSoMAs: Finding isoform expression and somatic mutation associations in human cancers","","Aberrant alternative splicing, common in cancer, reshapes key hallmarks such as proliferation, angiogenesis, and invasion. Splicing disruption frequently arises when somatic point mutations rewire functional pathways that help cancer cells survive. iSoMAs is introduced as an efficient computational pipeline using principal component analysis to test how somatic mutations affect transcriptome-wide isoform expression. Applied to 33 cancer types (9,738 tumor samples) from TCGA, it reveals 908 significantly associated somatically mutated genes across multiple cancers. cis- and trans-acting mechanisms are implicated, and wet-lab validation links TP53 mutations to altered isoform expression in cell-cycle genes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/isomas-finding-isoform-expression-and-somatic-mutation-associations-in-human-cancers/368454/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/isomas-finding-isoform-expression-and-somatic-mutation-associations-in-human-cancers/368454.png","ImageObject",300,407,{"name":42,"@type":43},"Kyle","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is iSoMAs designed to identify in cancer datasets?","Question",{"text":63,"@type":64},"iSoMAs is designed to find associations between somatic mutations and isoform-level gene expression across cancer types, focusing on how mutations influence transcriptome-wide splicing outputs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What analytical strategy does iSoMAs use?",{"text":68,"@type":64},"iSoMAs uses a principal component analysis (PCA) dimension-reduction approach to efficiently analyze sample-matched mutation and expression data.",{"name":70,"@type":61,"acceptedAnswer":71},"How was iSoMAs validated beyond computational results?",{"text":72,"@type":64},"The study used wet-lab experiments to verify a direct association between TP53 mutations and differential isoform expression in cell-cycle genes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368454,1790196920,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","OPEN ACCESS  \nCitation: Tan H, Gotea V, Jaiswal SK, Seidel NE, Holland DO, Fedkenheuer K, et al. (2025) iSoMAs: Finding isoform expression and somatic mutation associations in human cancers. PLoS Comput Biol 21(3): e1012847 .  \n[https://doi.org/10.1371/journal.pcbi.1012847](https://doi.org/10.1371/journal.pcbi.1012847)  \nEditor: Simone Zaccaria, University College London, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  \nReceived: May 15, 2024  \nAccepted: February 3, 2025  \nPublished: March 7, 2025  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pcbi.1012847  \nCopyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.  \nRESEARCH ARTICLE  \niSoMAs: Finding isoform expression and somatic mutation associations in human cancers  \nHua Tan1, Valer Gotea1, Sushil K. Jaiswal1, Nancy E. Seidel1, David O. Holland1,  \nKevin Fedkenheuer1, Abdel G. Elkahloun2, Sara R. Bang-Christensen1, Laura Elnitski1, *  \n1 Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America, 2 Microarrays and Single-Cell Genomics Core, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America  \n* [elnitski@nih.gov](elnitski@nih.gov)  \nAbstract  \nAberrant alternative splicing, prevalent in cancer, impacts various cancer hallmarks involving proliferation, angiogenesis, and invasion. Splicing disruption often results from somatic point mutations rewiring functional pathways to support cancer cell survival. We introduce iSoMAs (iSoform expression and somatic Mutation Association), an efficient computational pipeline leveraging principal component analysis technique, to explore how somatic mutations influence transcriptome-wide gene expression at the isoform level. Applying iSoMAs to 33 cancer types comprising 9,738 tumor samples in The Cancer Genome Atlas, we identified 908 somatically mutated genes significantly associated with altered isoform expression across three or more cancer types. Mutations linked to differential isoform expression occurred through both cis-and trans-acting mechanisms, involving well-known oncogenes/suppressor genes, RNA binding protein and splicing factor genes. With wetlab experiments, we verified direct association between TP53 mutations and differential isoform expression in cell cycle genes. Additional iSoMAs genes have been validated in the literature with independent cohorts and/or methods. Despite the complexity of cancer, iSoMAs attains computational efficiency via dimension reduction strategy and reveals critical associations between regulatory factors and transcriptional landscapes.  \nAuthor summary  \nSomatic single nucleotide variants (SNVs) drive human cancer progression by disrupting alternative splicing (AS), a co-transcriptional process that generates transcript variation and proteome diversity. To better understand the regulatory networks governing splicing, we propose a computational pipeline, iSoMAs (iSoform expression and somatic Mutation Association), and systematically investigate associations between SNVs and isoform expression in a pan-cancer analysis. Our approach leverages principal component analysis (PCA) for dimension reduction in sample-matched mutation and expression data from The Cancer Genome Atlas (TCGA). We identify thousands of  \nPLOS Computational Biology | [https://doi.org/10.1371/journal.pcbi.1012847](https://doi.org/10.1","cbCaikFpipiPIVlI","https://ap.wps.com/l/cbCaikFpipiPIVlI","pdf",5195021,39,"English","# Abstract\n# Author summary\n# Introduction","[{\"question\":\"What is iSoMAs designed to identify in cancer datasets?\",\"answer\":\"iSoMAs is designed to find associations between somatic mutations and isoform-level gene expression across cancer types, focusing on how mutations influence transcriptome-wide splicing outputs.\"},{\"question\":\"What analytical strategy does iSoMAs use?\",\"answer\":\"iSoMAs uses a principal component analysis (PCA) dimension-reduction approach to efficiently analyze sample-matched mutation and expression data.\"},{\"question\":\"How was iSoMAs validated beyond computational results?\",\"answer\":\"The study used wet-lab experiments to verify a direct association between TP53 mutations and differential isoform expression in cell-cycle genes.\"}]","iSoMAs: Finding isoform expression and somatic mutation associations in human cancers | PDF",1790177034,98,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1796562a14aee063b52932f1bbef9e2.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a88382630a04407b5b86d7eba8de0656.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e7e15f2962da6e9fddc8c62587da42f4.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b66886ce85ffc8013493661f10ceebf9.webp",980,1268]